Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MPW vs SBRA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBRA Captures Overall Composite Edge (56.4 HOLD vs 52.6 HOLD), While MPW Leads 4–2 on Growth & Valuation Pillars

SBRA Overall Winner 6-Pillar Tally: MPW 4 – 2 SBRA Matrix Metrics: MPW 4 – 6 SBRA

As of Nov 16, 2026, Sabra Healthcare REIT, Inc. (SBRA) captures the overall head-to-head institutional edge over Medical Properties Trust, Inc. (MPW) on higher Unified Composite conviction (56.4/100 HOLD vs. 52.6/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Options & Positioning), while MPW wins 4–2 across the 6-pillar growth and valuation breakdown. MPW trades at $5.02 (6.7x Forward P/E, 58.2% operating margin) versus SBRA at $20.42 (28.2x Forward P/E, 18.4% operating margin).

  • Growth vs. Quality Trade-Off: SBRA earns the overall head-to-head edge with a stronger Unified Composite Score (56.4/100 HOLD vs. MPW 52.6/100 HOLD) and -0.01β · 31% Vol risk profile, whereas MPW leads top-line expansion (+9.9% YoY revenue growth, 1.93x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MPW vs SBRA
MPW NYSE
Medical Properties Trust, Inc.
Real Estate Investment Trusts
$5.02
-0.59% 1D
Market Cap $3.0B
TTM Revenue $1.01B
Forward P/E 6.7x
Beta / 30D Vol 0.14β · 26% Vol
Unified Composite Score
52.6 / 100 HOLD
Tech 25.0 Fund 45.0 Flow 67.0 Mom 47.3
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 42.4 · SMA20: $5.18 · SMA50: $5.24
SBRA NASDAQ Head-to-Head Winner
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.42
-0.1% 1D
Market Cap $5.4B
TTM Revenue $924M
Forward P/E 28.2x
Beta / 30D Vol -0.01β · 31% Vol
Unified Composite Score
56.4 / 100 HOLD
Tech 43.0 Fund 56.0 Flow 74.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 53.2 · SMA20: $20.17 · SMA50: $19.88

6-Pillar Scorecard Institutional Category Breakdown (MPW 4 – 2 SBRA)

Columns: Metric · MPW · SBRA
1. Valuation Multiples MPW
Forward P/E 6.7x 28.2x
Trailing P/E 6.7x 76.2x
PEG Ratio 1.93x 5.28x
EV / Revenue 3.0x 8.4x
2. Growth & Scale SBRA
Revenue Growth (YoY) +9.9% +31.6%
Earnings Growth (YoY) -48.6% +22.2%
TTM Revenue (USD) $1.01B $924M
Market Cap $3.0B $5.4B
3. Profitability & Quality MPW
Gross Margin 96.4% 49.6%
Operating Margin 58.2% 18.4%
Net Profit Margin -70.1% 7.7%
Return on Equity (ROE) -14.0% 2.5%
4. Balance Sheet & Cash Flow MPW
Cash Generation (TTM) $823M EBITDA $401M
Cash Flow Margin 81.6% EBITDA Mgn 43.3%
Net Cash / Leverage $7.75 Book/Sh · -14.0% ROE $2.42B Net Debt (0.86x D/E)
Dividend Yield 6.34% 5.72%
5. Options & Positioning SBRA
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 24.3% (25th %ile) 21.6% (6th %ile)
Put/Call OI Skew 0.79x (Call-Skewed) 0.11x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat MPW
OpEx & R&D Intensity 38.2% of Rev ($385M) 31.2% of Rev ($288M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MPW (4) vs SBRA (6)
Institutional Metric MPW SBRA Criterion Row Edge
Market Capitalization
Scale
$3.0B $5.4B Larger Scale SBRA
Trailing P/E Ratio
Valuation
6.7x 76.2x Lower Multiple MPW
Forward P/E Ratio
Valuation
6.7x 28.2x Lower Multiple MPW
Revenue Growth (YoY)
Growth
+9.9% +31.6% Higher Growth SBRA
Operating Margin (TTM)
Profitability
58.2% 18.4% Higher Margin MPW
Net Profit Margin
Profitability
-70.1% 7.7% Higher Margin SBRA
Return on Equity (ROE)
Capital Efficiency
-14.0% 2.5% Higher ROE SBRA
52-Week Range Position
Momentum
45% ($4–$6) 55% ($18–$23) Stronger Trend SBRA
Beta / 30D Volatility
Risk Regime
0.14β · 26% Vol -0.01β · 31% Vol Lower Realized Risk MPW
Unified Institutional Score
Composite Signal
52.6 / 100 (HOLD) 56.4 / 100 (HOLD) Higher Composite SBRA
Trailing 12M Revenue (USD)
Operating Scale
$1.01B $924M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
96.4% 49.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.93x PEG · 3.0x EV/Rev 5.28x PEG · 8.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$823M EBITDA ($7.75 Book/Sh · -14.0% ROE) $401M ($2.42B Net Debt (0.86x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MPW +0.58 pp
MPW: -0.79% · SBRA: -1.37%
3M Horizon MPW +0.53 pp
MPW: +0.8% · SBRA: +0.27%
6M Horizon MPW +0.53 pp
MPW: +0.8% · SBRA: +0.27%
1Y Horizon MPW +0.53 pp
MPW: +0.8% · SBRA: +0.27%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MPW vs SBRA. Trailing 12-month operating profitability (MPW 58.2% vs SBRA 18.4%) and valuation multiples (MPW 6.7x vs SBRA 28.2x Forward P/E) are benchmarked directly in Pillar 4 below.

MPW ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.01B
Gross Margin96.4%
Op. Margin58.2%
ROE / Fwd P/E-14.0% · 6.7x
SBRA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$924M
Gross Margin49.6%
Op. Margin18.4%
ROE / Fwd P/E2.5% · 28.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MPW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 24.3%
IV Percentile 25th %ile
Put/Call OI Skew 0.79x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MPW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SBRA CONSOLIDATION
79d in phase · OBV DISTRIBUTION
Current IV 21.6%
IV Percentile 6th %ile
Put/Call OI Skew 0.11x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SBRA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MPW Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $3.0B market capitalization and 58.2% operating margin.
OpEx & R&D Reinvestment 38.2% of Rev ($385M)
90D Engineering Disclosures 0 Published
SBRA Moat Profile Scale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $5.4B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 31.2% of Rev ($288M)
90D Engineering Disclosures 0 Published

Investor FAQ MPW vs SBRA Key Questions & Quantitative Answers

As of Nov 16, 2026, Sabra Healthcare REIT, Inc. (SBRA) captures the overall head-to-head institutional edge over Medical Properties Trust, Inc. (MPW) on higher Unified Composite conviction (56.4/100 HOLD vs. 52.6/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Options & Positioning), while MPW wins 4–2 across the 6-pillar growth and valuation breakdown. MPW trades at $5.02 (6.7x Forward P/E, 58.2% operating margin) versus SBRA at $20.42 (28.2x Forward P/E, 18.4% operating margin). Growth vs. Quality Trade-Off: SBRA earns the overall head-to-head edge with a stronger Unified Composite Score (56.4/100 HOLD vs. MPW 52.6/100 HOLD) and -0.01β · 31% Vol risk profile, whereas MPW leads top-line expansion (+9.9% YoY revenue growth, 1.93x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.

SBRA leads the Growth & Scale pillar: MPW posts +9.9% YoY revenue growth and -48.6% YoY earnings growth on $1.01B TTM revenue (96.4% gross margin, 58.2% operating margin), compared with SBRA at +31.6% YoY revenue growth and +22.2% YoY earnings growth on $924M TTM revenue (49.6% gross margin, 18.4% operating margin). On trailing 12-month operating scale, MPW generates $1.01B in USD-normalized revenue versus $924M for SBRA. In operating R&D and SG&A reinvestment, MPW deploys 38.2% of Rev ($385M) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($288M) (0 disclosures) for SBRA.

MPW screens cheaper on headline valuation multiples. MPW trades at 6.7x Forward P/E, 6.7x Trailing P/E, 1.93x PEG, and 3.0x EV/Revenue (81.6% EBITDA margin), whereas SBRA trades at 28.2x Forward P/E, 76.2x Trailing P/E, 5.28x PEG, and 8.4x EV/Revenue (43.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MPW (-14.0% ROE) versus SBRA (2.5% ROE) capital efficiency.

In options market volatility and institutional positioning, MPW carries 24.3% implied volatility (25th %ile, Balanced (25th–60th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 26% Vol realized risk). By comparison, SBRA carries 21.6% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.01β · 31% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.